Cargando…
Response to letter, ‘Immortal time bias in retrospective analysis'
Autores principales: | Dimopoulos, M A, Swern, A S, Li, J S, Hussein, M, Weiss, L, Nagarwala, Y, Baz, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526781/ https://www.ncbi.nlm.nih.gov/pubmed/26230951 http://dx.doi.org/10.1038/bcj.2015.55 |
Ejemplares similares
-
Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
por: Dimopoulos, M A, et al.
Publicado: (2014) -
Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma'
por: Hsieh, P-Y, et al.
Publicado: (2015) -
Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect
por: Al Jurdi, Ayman, et al.
Publicado: (2023) -
Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect
por: Riggs, Julie M., et al.
Publicado: (2023) -
A Note on “A Catalog of Biases in Questionnaires” [Response to Letter]
por: Choi, Bernard C.K., et al.
Publicado: (2004)